Delivery Order SPE2DB22D1017-SPE2DB25FE8WD
Award Date
11/8/24
Potential Completion Date
12/3/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,399.71 fixed-price delivery order is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication, with a completion date of November 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,862.79 firm fixed-price delivery order is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,241.86 firm fixed-price delivery order is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of February 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,905.51, is a delivery order for the drug ZEPOSIA 0.92 MG CAPSULE 30S. The contract is a firm fixed-price, with an ultimate completion date of April 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,862.79 firm fixed-price delivery order contract is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,399.71 firm fixed-price delivery order is for the provision of ZEPOSIA 0.92 MG CAPSULE 30S, a specialty medication. The contract has an ultimate completion date of November 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $13,399.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a medication used for various medical conditions. The contract has a firm fixed price pricing type and an ultimate completion date of February 1, 2024. The contract was not set aside for any specific business size or...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,399.71 firm-fixed-price delivery order contract is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of November 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,466.57 firm fixed-price delivery order is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a specialty medication. The contract has an ultimate completion date of November 14, 2024 and was awarded on October 23, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $13,399.71 firm-fixed-price delivery order contract is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of October 1, 2024. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...